New and future headache devices

Professor Alan Rapoport provides a holistic overview of new and upcoming devices for patients with headache. 

Z

n/a

Alan M. Rapoport M.D. serves as an advisor for Allergan, Amgen, Biohaven, Cala Health, Novartis, Satsuma, Teva Pharmaceutical Industries, Theranica, Xoc and Zosano; he is on the speaker bureau of Allergan, Amgen, Biohaven, Lundbeck and Teva Pharmaceutical Industries.